Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep323 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Programmed cell death-1 inhibitor-induced Type 1 Diabetes Mellitus – an interesting case presenting with diabetic ketoacidosis

Maia Ariana , Rodrigues Catarina Cidade , Soares Daniela , Monteiro Silvia Santos , Pereira Maria Teresa , Amaral Claudia , Cardoso Maria Helena

Introduction: Immunotherapy has demonstrated a key role in the current individualized treatment of multiple neoplasms, with adverse events related to the endocrine. Thyroid dysfunction is the most frequent reported endocrine event during treatment with pembrolizumab, being autoimmune diabetes an extremely rare adverse effect.Case Report: We present a case of a 72-year-old man with a progressing urothelial bladder carcinoma (stage IIIB), under treatment w...